دورية أكاديمية

Liquid biopsy: A promising tool for driving strategies and predicting failures in patients with classic Hodgkin lymphoma.

التفاصيل البيبلوغرافية
العنوان: Liquid biopsy: A promising tool for driving strategies and predicting failures in patients with classic Hodgkin lymphoma.
المؤلفون: Pepe, Francesco, Giordano, Claudia, Russo, Gianluca, Palumbo, Lucia, Vincenzi, Annamaria, Acanfora, Gennaro, Lisi, Dario, Picardi, Marco, Pane, Fabrizio, Troncone, Giancarlo, Vigliar, Elena
المصدر: Cytopathology; Mar2024, Vol. 35 Issue 2, p182-187, 6p
مصطلحات موضوعية: HODGKIN'S disease, NUCLEOTIDE sequencing, B cells, BIOPSY, LIQUIDS
مستخلص: Classic Hodgkin lymphoma (cHL) consists of a heterogeneous group of haematological disorders that covers undifferentiated B cell neoplasms originating from germinal centre B cells. The HL molecular characterization still represents an ongoing challenge due to the low fraction of tumour Hodgkin and Reed–Sternberg cells mixed with a plethora of non‐tumour haematological cells. In this scenario, next generation sequencing of liquid biopsy samples is emerging as a useful tool in HL patients' management. In this review, we aimed to overview the clinical and methodological topics regarding the implementation of molecular analysis in cHL, focusing on the role of liquid biopsy in diagnosis, follow‐up, and response prediction. [ABSTRACT FROM AUTHOR]
Copyright of Cytopathology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:09565507
DOI:10.1111/cyt.13255